Artiva Biotherapeutics, Inc. (ARTV) Operating income 2023–2025
Artiva Biotherapeutics, Inc. (ARTV) annual operating income history from SEC filings — each fiscal year as reported.
-$89.8MFY2025 · since FY2023: -$30.7M → -$89.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$89.8M | -33.5% |
| FY2024 | -$67.3M | -119.4% |
| FY2023 | -$30.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ARTV financial trends
ARTV RevenueARTV Net incomeARTV Net marginARTV Gross profitARTV Gross marginARTV Operating marginARTV Operating cash flowARTV Free cash flowARTV Capital expendituresARTV Return on equityARTV Stock buybacksARTV Dividends paidARTV Total assetsARTV Total liabilitiesARTV Shareholders’ equityARTV overview →